Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
APS La Belle is a premier global producer of bovine colostrum and a specialized contract manufacturer of nutritional supplements. Formed through the integration of APS BioGroup and La Belle Associates, the company provides high-quality, science-backed colostrum ingredients and finished products for human and animal health. In 2023, the company was acquired by Glanbia Nutritionals from PanTheryx, solidifying its position within a leading global nutrition group. APS La Belle operates state-of-the-art manufacturing facilities in Phoenix, Arizona, and Ripon, California, utilizing advanced technologies such as spray drying and dry blending. Its product portfolio, including the flagship ColostrumOne and Immulox brands, supports immune function, gut health, and athletic recovery across more than 50 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on APS La Belle.